Hyperekplexia and sudden neonatal death
- PMID: 1622521
- DOI: 10.1016/0887-8994(92)90073-8
Hyperekplexia and sudden neonatal death
Abstract
Fifteen patients with hyperekplexia were identified in 3 families; diagnostic clinical characteristics were defined which allowed for early recognition and treatment. During the first 24 hours of life, spontaneous apnea and sluggish feeding effort were observed. After the first 24 hours, surviving infants exhibited the hyperekplexic startle response to nose tapping. This startle response is characterized by sudden muscular rigidity, feeding-induced oropharyngeal incoordination, and poor air exchange often with apnea, persisting with repetitive nose tapping. Untreated infants experienced recurring apnea until 1 year of age. Three of 15 patients died unexpectedly during the neonatal period. Patients treated with clonazepam (0.1-0.2 mg/kg/day) had no serious apneic episodes and startle reflexes were diminished. The pathophysiologic mechanism for hyperekplexia remains obscure. Electroencephalographic studies were consistently normal. The response to and tolerance of benzodiazepines are striking in newborns and infants and suggest an aberrant central nervous system reflex as the etiology; therefore, hyperekplexia should be considered in the evaluation of neonates and infants with apnea, aspiration pneumonia, episodic muscular rigidity, hyperexcitability, and near-miss sudden infant death syndrome. The need for immediate monitoring of at-risk infants, observation for signs of hyperekplexia, and initiation of clonazepam in these patients are emphasized. Hyperekplexic startle response to nose tapping should be included in the routine examination of all newborns.
Similar articles
-
Hyperekplexia in neonates.Postgrad Med J. 2001 Sep;77(911):570-2. doi: 10.1136/pmj.77.911.570. Postgrad Med J. 2001. PMID: 11524514 Free PMC article. Review.
-
Complete heart block in nonfamilial hyperekplexia.Pediatr Neurol. 1995 Feb;12(2):149-51. doi: 10.1016/0887-8994(94)00111-e. Pediatr Neurol. 1995. PMID: 7779213
-
[Hyperekplexia -- a treatable neuropediatric disease].Klin Padiatr. 2005 Jul-Aug;217(4):220-1. doi: 10.1055/s-2004-820286. Klin Padiatr. 2005. PMID: 16032547 German.
-
Hyperekplexia: a treatable neurogenetic disease.Brain Dev. 2002 Oct;24(7):669-74. doi: 10.1016/s0387-7604(02)00095-5. Brain Dev. 2002. PMID: 12427512 Review.
-
Hyperekplexia.Arch Neurol. 1983 Apr;40(4):246-8. doi: 10.1001/archneur.1983.04050040076015. Arch Neurol. 1983. PMID: 6830476
Cited by
-
Movement disorder emergencies.J Neurol. 2008 Aug;255 Suppl 4:2-13. doi: 10.1007/s00415-008-4002-9. J Neurol. 2008. PMID: 18821080 Review.
-
A novel syndrome of lethal familial hyperekplexia associated with brain malformation.BMC Neurol. 2012 Oct 27;12:125. doi: 10.1186/1471-2377-12-125. BMC Neurol. 2012. PMID: 23101555 Free PMC article.
-
Myoclonus and epilepsies.Indian J Pediatr. 1997 Sep-Oct;64(5):583-602. doi: 10.1007/BF02726110. Indian J Pediatr. 1997. PMID: 10771893 Review.
-
Hyperekplexia in neonates.Postgrad Med J. 2001 Sep;77(911):570-2. doi: 10.1136/pmj.77.911.570. Postgrad Med J. 2001. PMID: 11524514 Free PMC article. Review.
-
A microdeletion at Xq22.2 implicates a glycine receptor GLRA4 involved in intellectual disability, behavioral problems and craniofacial anomalies.BMC Neurol. 2016 Aug 9;16:132. doi: 10.1186/s12883-016-0642-z. BMC Neurol. 2016. PMID: 27506666 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical